Discipline
Hematology, cytapheresis, cellular therapy
Hematology, cytapheresis, cellular therapy
Programme mentors
Dr. Anne-Sophie Michallet, Dr. Emmanuelle Nicolas Virelzier, Dr. Amine Belhabri, Prof. Mauricette Michallet
Dr. Anne-Sophie Michallet, Dr. Emmanuelle Nicolas Virelzier, Dr. Amine Belhabri, Prof. Mauricette Michallet
Duration
3 - 6 months
3 - 6 months
Type
Visiting Residency and Visiting Observership
Visiting Residency and Visiting Observership
Language requirements
Good knowledge of French or English required. Very good knowledge of French required for residency
Good knowledge of French or English required. Very good knowledge of French required for residency
Programme description
- Dedicated programs of new drugs in CLL and NHL
- Place of the new combination treatment using new drugs + chemotherpy in myelodysplasia and acute myeloid leukemia specifically in older population
- Developement of CAR T cells in NHL, HD and CLL in clinical trials or in academic use
- Developement of CAR T cells in rare oncologic tumors
- Standard management of hematological malignancies ( NHL, HD, Myeloma, CLL, MDS)
